Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Rosiglitazone neuroprotective mechanism in experimental stroke elucidated

Feb. 26, 2008

JuvImmune protects mice against lethal pneumonic infection

Feb. 26, 2008

Prostate-specific membrane antigen DNA vaccine safe in renal cell carcinoma patients

Feb. 26, 2008

Novel 5-HT6 receptor antagonist potentially useful as cognition enhancer

Feb. 25, 2008

Positive preclinical results with staphylococcal enterotoxin B vaccine (STEBVax)

Feb. 25, 2008

Association between GVAX-induced immune responses and survival in patients with prostate cancer

Feb. 22, 2008

Antiangiogenic gene therapy potentially useful for metastatic renal cell carcinoma

Feb. 22, 2008

No viral resistance to R-7128 seen in HCV genotype 1 patients

Feb. 22, 2008

Abiraterone active in phase I and II studies in castration-resistant prostate cancer

Feb. 21, 2008

Mixed results seen with PI-88-docetaxel in hormone-refractory prostate cancer

Feb. 21, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...